Prolonged vemurafenib treatment in BRAFV600E melanoma cell lines induces actin cytoskeletal remodeling, which increases YAP/TAZ nuclear localization and promotes drug resistance and cancer cell viability [33]. The gene discussed is YAP1; the disease is cancer.